ABR-238901
ABR-238901 is an oral, active S100A8/A9 blocker that inhibits the interaction of S100A8/A9 with its receptors RAGE (receptor for advanced glycation end products) and TLR4 (toll-like receptor 4) . ABR-238901 has potential as a compound for the treatment of myocardial infarction (MI) .
Product Specifications
CAS Number
1638200-22-2
Stability
≥ 2 years
Purity
>98% (HPLC)
Weight
394.63
Molecular Formula
C11H9BrClN3O4S
Notes
Research use only, not for human use.
Receptor
TLR
Available Sizes
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
NBP3-28465JF669 0.1 mL
Human Monoclonal EGFR Antibody (imgatuzumab) [Janelia Fluor 669]
Ask
View Details